文献速递肿瘤 PET/CT核素与放射性配体治疗神经核医学

异位CRH分泌性胰腺神经内分泌肿瘤肝转移对PRRT显效的PET/CT影像

Ectopic Corticotropin-Releasing Hormone-Secreting Pancreatic Neuroendocrine Tumor: Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET/CT Imaging.
PubMed 文献 · Clin Nucl Med · 2020-01-01

Ectopic Cushing syndrome secondary to corticotropin releasing hormone (CRH)-secreting tumors or CRH and adrenocorticotropin hormone cosecreting tumors is extremely rare.…

要点

  • CRH分泌性胰腺神经内分泌肿瘤致异位库欣综合征极罕见,可伴肝转移。
  • 68Ga-DOTATOC与18F-FDG PET/CT可显示SSTR高表达及「不匹配」模式。

研究设计与样本

  • 个案报告:一例54岁男性CRH分泌性胰腺神经内分泌肿瘤致库欣综合征患者。

主要发现

  • 初由SSTR显像检测发现,后疾病显著进展出现多发肝转移。
  • 68Ga-DOTATOC PET/CT示肝转移SSTR表达显著增高。
  • 18F-FDG PET/CT呈「不匹配」成像模式。

临床怎么用

  • 对CRH分泌性神经内分泌肿瘤可利用68Ga-DOTATOC与18F-FDG PET/CT评估SSTR表达及代谢特征。
  • SSTR高表达且呈「不匹配」模式的多发肝转移可考虑肽受体放射性核素治疗。

局限性

  • 本文为单例个案报告,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ectopic Cushing syndrome secondary to corticotropin releasing hormone (CRH)-secreting tumors or CRH and adrenocorticotropin hormone cosecreting tumors is extremely rare. We report here the case of a 54-year-old man who experienced CRH-secreting pancreatic neuroendocrine tumor causing Cushing syndrome, initially detected by SSTR (somatostatin receptor) scintigraphy, then significantly progressed with multiple liver metastases, demonstrating significantly increased SSTR expression on Ga-DOTATOC PET/CT and a "mismatch" imaging pattern on F-FDG PET/CT. The patient underwent peptide receptor radionuclide therapy with Lu/Y-DOTATOC and demonstrated excellent response to the treatment.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Zhang J, Kulkarni HR, Baum RP, et al. Ectopic Corticotropin-Releasing Hormone-Secreting Pancreatic Neuroendocrine Tumor: Excellent Response of Liver Metastases to Peptide Receptor Radionuclide Therapy as Demonstrated by 68Ga-DOTATOC and 18F-FDG PET/CT Imaging. Clin Nucl Med. 2020. PMID: 31714276. doi:10.1097/RLU.0000000000002834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。